Scopeora News & Life

© 2026 Scopeora News & Life

Immunotherapy

Breakthrough Immunotherapy Trial Achieves 100% Success Rate in Bowel Cancer Patients

Breakthrough Immunotherapy Trial Achieves 100% Success Rate in Bowel Cancer Patients

For many years, the conventional treatment for bowel cancer involved a rigorous sequence of surgery followed by chemotherapy, with the hope of prevent...

Promising Immunotherapy Drug for Prostate Cancer Achieves Remarkable Biomarker Reductions
Health
Promising Immunotherapy Drug for Prostate Cancer Achieves Remarkable Biomarker Reductions

Prostate cancer, one of the most commonly diagnosed cancers among men globally, has long posed challenges for the immune...